Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
0,00%
Bitcoin
95.354,85
-3,97%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Anixa Biosciences Inc (ANIX) Anixa Biosciences Inc (ANIX) Notizie

Anixa Biosciences Inc

ANIX
2,58
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 13:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/12/202414:30PRNUSAnixa Biosciences to Present at the iAccess Alpha Virtual..
22/11/202414:15PRNUSAnixa Biosciences Board of Directors Approves Purchase of..
18/11/202414:20PRNUSAnixa Biosciences Initiates Dosing in Third Cohort in its..
08/11/202419:31EDGAR2Form 8-K - Current report
08/11/202419:17PRNUSAnixa Biosciences and Cleveland Clinic Present New Updated..
06/11/202414:30PRNUSAnixa Biosciences Announces Timing of Public Release of Data..
31/10/202413:15PRNUSAnixa Biosciences to Present at the Sidoti Micro-Cap Virtual..
28/10/202413:30PRNUSAnixa Biosciences and Cleveland Clinic to Present Additional..
23/10/202417:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/10/202415:00PRNUSAnixa Biosciences Announces Second Dose Administered to..
07/10/202414:30PRNUSAnixa Biosciences Appoints Suyasha Gupta as Senior Director..
30/9/202414:30PRNUSAnixa Biosciences Announces Submission of Protocol Amendment..
24/9/202414:30PRNUSAnixa Biosciences Unveils Phase 2 Study Plan for Breast..
18/9/202414:30PRNUSAnixa Biosciences Announces Presentation on its Ovarian..
06/9/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/9/202414:30PRNUSAnixa Biosciences Announces Presentation on its Ovarian..
26/8/202414:30PRNUSAnixa Biosciences to Present at the H.C. Wainwright 26th..
01/8/202418:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/7/202414:45PRNUSAnixa Biosciences Announces Presentation on its Ovarian..
29/7/202412:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202419:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/7/202414:15PRNUSAnixa Biosciences Announces FDA Approval of Individual..
17/7/202414:00PRNUSAnixa Biosciences Announces Japanese Patent on Breast Cancer..
15/7/202414:30PRNUSAnixa Biosciences Announces $5 Million Share Repurchase..
24/6/202414:45PRNUSAnixa Biosciences Treats Sixth Patient in its Ovarian Cancer..
18/6/202415:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202415:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202417:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202418:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202416:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
21/5/202413:30PRNUSAnixa Biosciences Commences Treatment of Fifth Patient in..
08/5/202414:35EDGAR2Form 8-K - Current report
08/5/202414:25PRNUSAnixa Biosciences Expands Partnership with Cleveland Clinic..
06/5/202414:05PRNUSAnixa Biosciences CEO Featured on "Target: Cancer Podcast"..
30/4/202413:45PRNUSAnixa Biosciences to Participate in the Sidoti Micro-Cap..
18/4/202414:20PRNUSAnixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay..
14/3/202413:45PRNUSAnixa Biosciences 2024 Annual Meeting of Stockholders to..
11/3/202413:00PRNUSAnixa Biosciences Announces Presentation at 24th Annual..
12/2/202413:30PRNUSAnixa Biosciences Initiates Dosing in Second Cohort of..
08/2/202422:15EDGAR2Form DEF 14A - Other definitive proxy statements
29/1/202414:50PRNUSAnixa Biosciences Announces Participation in 2024..
23/1/202413:55PRNUSAnixa Biosciences Announces Japanese Patent on Ovarian..
17/1/202401:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202423:29EDGAR2Form SC 13D/A - General statement of acquisition of..
Apertura: Min: Max:
Chiusura: 2,58

La tua Cronologia

NASDAQ
ANIX
Anixa Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network